531
Views
31
CrossRef citations to date
0
Altmetric
Drug Evaluations

Clinical development of IMOJEV®—a recombinant Japanese encephalitis chimeric vaccine (JE-CV)

&
Pages 1251-1263 | Published online: 09 Jul 2012

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Ya-Li Hu & Ping-Ing Lee. (2021) Safety of Japanese encephalitis vaccines. Human Vaccines & Immunotherapeutics 17:11, pages 4259-4264.
Read now
Tomáš Hanke. (2014) Conserved immunogens in prime-boost strategies for the next-generation HIV-1 vaccines. Expert Opinion on Biological Therapy 14:5, pages 601-616.
Read now
Sang-Im Yun & Young-Min Lee. (2014) Japanese encephalitis. Human Vaccines & Immunotherapeutics 10:2, pages 263-279.
Read now
Igor S Lukashevich. (2013) The search for animal models for Lassa fever vaccine development. Expert Review of Vaccines 12:1, pages 71-86.
Read now

Articles from other publishers (27)

Faith A. A. Kwa, Evie Kendal & Junhua Xiao. (2023) An Overview of Japanese Encephalitis in Australia: Trends, Impact and Interventions. Applied Sciences 13:16, pages 9184.
Crossref
Nadezhda Kuznetsova, Andrei Siniavin, Alexander Butenko, Victor Larichev, Alina Kozlova, Evgeny Usachev, Maria Nikiforova, Olga Usacheva, Alexey Shchetinin, Andrei Pochtovyi, Elena Shidlovskaya, Alina Odintsova, Elizaveta Belyaeva, Aleksander Voskoboinikov, Arina Bessonova, Lyudmila Vasilchenko, Galina Karganova, Vladimir Zlobin, Denis Logunov, Vladimir Gushchin & Alexander Gintsburg. (2023) Development and characterization of chimera of yellow fever virus vaccine strain and Tick-Borne encephalitis virus. PLOS ONE 18:5, pages e0284823.
Crossref
Annaleise R. Howard-Jones, David Pham, Rebecca Sparks, Susan Maddocks, Dominic E. Dwyer, Jen Kok & Kerri Basile. (2023) Arthropod-Borne Flaviviruses in Pregnancy. Microorganisms 11:2, pages 433.
Crossref
Judy King Man Ng. 2023. Bioprocess and Analytics Development for Virus-based Advanced Therapeutics and Medicinal Products (ATMPs). Bioprocess and Analytics Development for Virus-based Advanced Therapeutics and Medicinal Products (ATMPs) 277 294 .
John S. Mackenzie & David T. Williams. (2022) Japanese encephalitis virus: an emerging and re-emerging virus in Australia. Microbiology Australia 43:4, pages 150-155.
Crossref
John S. Mackenzie, David T. Williams, Andrew F. van den Hurk, David W. Smith & Bart J. Currie. (2022) Japanese Encephalitis Virus: The Emergence of Genotype IV in Australia and Its Potential Endemicity. Viruses 14:11, pages 2480.
Crossref
David Pham, Annaleise R. Howard-Jones, Linda Hueston, Neisha Jeoffreys, Stephen Doggett, Rebecca J. Rockett, John-Sebastian Eden, Vitali Sintchenko, Sharon C-A. Chen, Matthew V. O'Sullivan, Susan Maddocks, Dominic E. Dwyer & Jen Kok. (2022) Emergence of Japanese encephalitis in Australia: a diagnostic perspective. Pathology 54:6, pages 669-677.
Crossref
Li-Hsin Li, Laurens Liesenborghs, Lanjiao Wang, Marleen Lox, Michael Bright Yakass, Sander Jansen, Ana Lucia Rosales Rosas, Xin Zhang, Hendrik Jan Thibaut, Dirk Teuwen, Johan Neyts, Leen Delang & Kai Dallmeier. (2022) Biodistribution and environmental safety of a live-attenuated YF17D-vectored SARS-CoV-2 vaccine candidate. Molecular Therapy - Methods & Clinical Development 25, pages 215-224.
Crossref
Enyue Fang, Xinyu Liu, Xiaohui Liu, Ming Li, Ling Wang, Miao Li, Zelun Zhang, Yuhua Li & Yongxin Yu. (2022) Investigation of immune response induction by Japanese encephalitis live‐attenuated and chimeric vaccines in mice. MedComm 3:2.
Crossref
Limin Yang, Aibo Xiao, Hu Wang, Xiaojuan Zhang, Yuan Zhang, Yunlong Li, Yanqiu Wei, Wenjun Liu & Chuangfu Chen. (2022) A VLP-Based Vaccine Candidate Protects Mice against Japanese Encephalitis Virus Infection. Vaccines 10:2, pages 197.
Crossref
Ming-Kai Jhan, Chia-Ling Chen, Ting-Jing Shen, Po-Chun Tseng, Yung-Ting Wang, Rahmat Dani Satria, Chia-Yi Yu & Chiou-Feng Lin. (2021) Polarization of Type 1 Macrophages Is Associated with the Severity of Viral Encephalitis Caused by Japanese Encephalitis Virus and Dengue Virus. Cells 10:11, pages 3181.
Crossref
Clairissa A. Hansen & Alan D. T. Barrett. (2021) The Present and Future of Yellow Fever Vaccines. Pharmaceuticals 14:9, pages 891.
Crossref
Robert T. Chen, Sonali Kochhar & Richard Condit. (2021) The Brighton Collaboration standardized templates for collection of key information for benefit-risk assessment of vaccines by technology (BRAVATO; formerly V3SWG). Vaccine 39:22, pages 3050-3052.
Crossref
Ping-Ing Lee, Yhu-Chering Huang, Kao-Pin Hwang, Ching-Chuan Liu, Cheng-Hsun Chiu, Po-Yen Chen, Chun-Yi Lu, Chih-Jung Chen, Luan-Yin Chang, Nan-Chang Chiu, Hsin Chi, Hsiao-Chuan Lin, Keh-Gong Wu, Yu-Huai Ho, Wu Sun & Tzou-Yien Lin. (2020) Recommendations for the use of Japanese encephalitis vaccines. Pediatrics & Neonatology 61:1, pages 3-8.
Crossref
Rong Huang, Shengling Leng, Yalan Feng, Liping Tang, Lei Yuan & Jian Yang. (2019) Chimeric Japanese Encephalitis Virus SA14/SA14-14-2 Was Virulence Attenuated and Protected the Challenge of Wild-Type Strain SA14. Canadian Journal of Infectious Diseases and Medical Microbiology 2019, pages 1-7.
Crossref
Bo Xiang, Trevor R. Baybutt, Lisa Berman-Booty, Michael S. Magee, Scott A. Waldman, Vitali Y. Alexeev & Adam E. Snook. (2017) Prime-Boost Immunization Eliminates Metastatic Colorectal Cancer by Producing High-Avidity Effector CD8+ T Cells. The Journal of Immunology 198:9, pages 3507-3514.
Crossref
Nidhi Jain, Neelam Oswal, Amanpreet Singh Chawla, Tanvi Agrawal, Moanaro Biswas, Sudhanshu Vrati, Satyajit Rath, Anna George, Vineeta Bal & Guruprasad R. Medigeshi. (2017) CD8 T cells protect adult naive mice from JEV-induced morbidity via lytic function. PLOS Neglected Tropical Diseases 11:2, pages e0005329.
Crossref
Douglas D. Richman, Richard J. Whitley & Frederick J. HaydenLyle R. Petersen & Alan D.T. Barrett. 2016. Clinical Virology. Clinical Virology 1267 1311 .
Richard C. Condit, Anna-Lise Williamson, Rebecca Sheets, Stephen J. Seligman, Thomas P. Monath, Jean-Louis Excler, Marc Gurwith, Karin Bok, James S. Robertson, Denny Kim, R. Michael Hendry, Vidisha Singh, Lisa M. Mac & Robert T. Chen. (2016) Unique safety issues associated with virus-vectored vaccines: Potential for and theoretical consequences of recombination with wild type virus strains. Vaccine 34:51, pages 6610-6616.
Crossref
Gregory D. Gromowski, Cai-Yen Firestone & Stephen S. Whitehead. (2015) Genetic Determinants of Japanese Encephalitis Virus Vaccine Strain SA14-14-2 That Govern Attenuation of Virulence in Mice. Journal of Virology 89:12, pages 6328-6337.
Crossref
Stephen S. Whitehead, José Bustos-Arriaga, Cai-Yen Firestone & Gregory D. Gromowski. (2015) Genetic and Phenotypic Properties of Vero Cell-Adapted Japanese Encephalitis Virus SA14-14-2 Vaccine Strain Variants and a Recombinant Clone, Which Demonstrates Attenuation and Immunogenicity in Mice. The American Journal of Tropical Medicine and Hygiene 92:1, pages 98-107.
Crossref
Rong-Hong Hua, Ye-Nan Li, Zhen-Shi Chen, Li-Ke Liu, Hong Huo, Xiao-Lei Wang, Li-Ping Guo, Nan Shen, Jing-Fei Wang & Zhi-Gao Bu. (2014) Generation and characterization of a new mammalian cell line continuously expressing virus-like particles of Japanese encephalitis virus for a subunit vaccine candidate. BMC Biotechnology 14:1.
Crossref
Carlo Amorin Daep, Jorge L. Muñoz-Jordán & Eliseo Alberto Eugenin. (2014) Flaviviruses, an expanding threat in public health: focus on dengue, West Nile, and Japanese encephalitis virus. Journal of NeuroVirology 20:6, pages 539-560.
Crossref
Sang-Im Yun, Byung-Hak Song, Jin-Kyoung Kim, Gil-Nam Yun, Eun-Young Lee, Long Li, Richard J. Kuhn, Michael G. Rossmann, John D. Morrey & Young-Min Lee. (2014) A Molecularly Cloned, Live-Attenuated Japanese Encephalitis Vaccine SA14-14-2 Virus: A Conserved Single Amino Acid in the ij Hairpin of the Viral E Glycoprotein Determines Neurovirulence in Mice. PLoS Pathogens 10:7, pages e1004290.
Crossref
Gregory D. Gromowski, Cai-Yen Firestone, Christopher T. Hanson & Stephen S. Whitehead. (2014) Japanese encephalitis virus vaccine candidates generated by chimerization with dengue virus type 4. Vaccine 32:25, pages 3010-3018.
Crossref
Shailendra K SaxenaNiharika Srivastava & Sneham Tiwari. (2013) Latency, persistence and reactivation of Japanese encephalitis virus. Future Virology 8:5, pages 427-430.
Crossref
Igor Lukashevich. (2012) Advanced Vaccine Candidates for Lassa Fever. Viruses 4:11, pages 2514-2557.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.